Taken together, these results suggest that the loss of wild-type p53 in the absence of mutant p53 might contribute to the invasion of benign tumors, although it is not sufficient to drive the process, and modifier gene alteration depending on genetic background may be required. This evidence concerns the gene TP53 and benign neoplasm.